Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nephros (NEPH) Depreciation & Amortization - Total (2019 - 2024)

Nephros has reported Depreciation & Amortization - Total over the past 11 years, most recently at $1000.0 for Q1 2024.

  • Quarterly results put Depreciation & Amortization - Total at $1000.0 for Q1 2024, changed 0.0% from a year ago — trailing twelve months through Dec 2024 was $1000.0 (down 66.67% YoY), and the annual figure for FY2023 was $3000.0, down 86.36%.
  • Depreciation & Amortization - Total for Q1 2024 was $1000.0 at Nephros, roughly flat from $1000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization - Total for NEPH hit a ceiling of $12000.0 in Q2 2022 and a floor of -$5000.0 in Q4 2021.
  • Median Depreciation & Amortization - Total over the past 4 years was $3000.0 (2022), compared with a mean of $3272.7.
  • Biggest five-year swings in Depreciation & Amortization - Total: soared 160.0% in 2022 and later crashed 91.67% in 2023.
  • Nephros' Depreciation & Amortization - Total stood at -$5000.0 in 2021, then soared by 160.0% to $3000.0 in 2022, then crashed by 66.67% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • The last three reported values for Depreciation & Amortization - Total were $1000.0 (Q1 2024), $1000.0 (Q3 2023), and $1000.0 (Q2 2023) per Business Quant data.